Ethereum treasury ETHZilla shifts to real estate tokenization, secures $4.7 million housing loan agreement
According to Odaily, Ethereum digital asset treasury ETHZilla (ETHZ) is accelerating its asset tokenization strategy, spending $4.7 million to acquire a portfolio of 95 manufactured and modular home loans. The company plans to tokenize these loans on the Ethereum Layer-2 network and issue cash flow-based digital tokens to investors via the regulated trading platform Liquidity.io.
This loan portfolio is secured by first-lien mortgages and is expected to yield an annualized return of approximately 10%. ETHZilla Chairman and CEO McAndrew Rudisill stated that this transaction is a natural extension of the company’s tokenization strategy. Manufactured home loans offer stable cash flows and strong collateral assets, making them highly suitable for tokenization within a regulated and transparent framework.
This move by ETHZilla comes after a significant decline in its core crypto assets. Since its peak of $107 in August 2025, the company’s stock price has dropped by more than 90%. Last year, ETHZilla sold over $110 million worth of ETH to fund stock buybacks and repay debt. Previously, ETHZilla also invested in manufactured home loan company Zippy and acquired two jet engines pending tokenization, demonstrating its ongoing advancement in the diversified real-world asset tokenization sector.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
